Fractyl Health, Inc.
GUTS
$1.92
$0.084.35%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 6.27% | -7.44% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -12.98% | 5.33% | |||
| Operating Income | 12.98% | -5.33% | |||
| Income Before Tax | -63.52% | -17.50% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -63.52% | -17.50% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -63.52% | -17.50% | |||
| EBIT | 12.98% | -5.33% | |||
| EBITDA | 13.19% | -5.48% | |||
| EPS Basic | -24.04% | -17.09% | |||
| Normalized Basic EPS | -26.55% | -11.37% | |||
| EPS Diluted | -24.04% | -17.09% | |||
| Normalized Diluted EPS | -26.55% | -11.37% | |||
| Average Basic Shares Outstanding | 31.83% | 0.36% | |||
| Average Diluted Shares Outstanding | 31.83% | 0.36% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||